JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

JNJ

227.3

-0.24%↓

ISRG

507.91

-2.78%↓

ABT

106.03

+0.05%↑

MDT

100.97

+0.31%↑

133.13

-0.58%↓

Kodu・Aktsiate loetelu・Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals Inc

Suletud

SektorTervishoid

1.43 -4.67

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

1.42

Max

1.54

Põhinäitajad
By Trading Economics
Sissetulek	-16M -13M
Müük	-15M 14M
Kasumimarginaal	-90.037
Töötajad	103
EBITDA	-16M -10M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+135.67% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	5. märts 2026

Turustatistika
By TradingEconomics
Turukapital	76M 571M
Eelmine avamishind	6.1
Eelmine sulgemishind	1.43

Uudiste sentiment

By Acuity

62%

38%

302 / 352 Pingereas Healthcare

Tehniline skoor

By Trading Central

Kindlus

Bearish Evidence

0.6863 / 0.72 Toetus ja vastupanu

Lexicon Pharmaceuticals Inc Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

29. jaan 2026, 22:31 UTC

Tulu

KLA Posts Higher 2Q Profit On Product and Services Sales Growth

29. jaan 2026, 22:05 UTC

Tulu

Stryker Logs Higher 4Q Profit On Sales Gains

29. jaan 2026, 21:54 UTC

Tulu

Visa 1Q Sales Climb on Strong Holiday Shopping -- Update

29. jaan 2026, 21:36 UTC

Tulu

Visa 1Q Sales Climb on Strong Holiday Shopping

29. jaan 2026, 23:57 UTC

Omandamised, ülevõtmised, äriostud

Aluminum Corp. of China: to Hold 67% of Joint Venture With Rio Tinto

29. jaan 2026, 23:56 UTC

Omandamised, ülevõtmised, äriostud

Aluminum Corp. of China: Deal Valued at Roughly BRL4.69 Billion

29. jaan 2026, 23:53 UTC

Omandamised, ülevõtmised, äriostud

Aluminum Corp. of China Says It, Rio Tinto Propose to Buy 69% Stake in Companhia Brasileira de Aluminio S.A.

29. jaan 2026, 23:51 UTC

Tulu

Correction to Intel Earnings Article on Jan. 22 -- WSJ

29. jaan 2026, 23:49 UTC

Market Talk

Nikkei May Decline After Wall Street Tech Selloffs -- Market Talk

29. jaan 2026, 23:49 UTC

Market Talk

Gold Rises Amid Ongoing Iran Tensions -- Market Talk

29. jaan 2026, 23:47 UTC

Market Talk

Pro Medicus Looks Attractive Ahead of 1H Result -- Market Talk

29. jaan 2026, 23:35 UTC

Tulu

Apple Posts Blowout iPhone Sales on Surging China Demand -- 2nd Update

29. jaan 2026, 23:32 UTC

Market Talk

REA's 1H Result Could Jolt Share Price More Than Usual -- Market Talk

29. jaan 2026, 23:32 UTC

Market Talk

Global Equities Roundup: Market Talk

29. jaan 2026, 23:15 UTC

Market Talk

Tulu

Visa Says High Earners Still Lead Spending Growth -- Market Talk

29. jaan 2026, 22:27 UTC

Tulu

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29. jaan 2026, 22:27 UTC

Tulu

GE Vernova Gains After Earnings. Guidance Boost Was Enough to Lift the Stock. -- Barrons.com

29. jaan 2026, 22:12 UTC

Tulu

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29. jaan 2026, 21:55 UTC

Tulu

Micron Stock Rises. Samsung Signals a 'Golden Era' for Memory Chips. -- Barrons.com

29. jaan 2026, 21:50 UTC

Market Talk

Tulu

Financial Services Roundup: Market Talk

29. jaan 2026, 21:50 UTC

Tulu

These Stocks Are Today's Movers: Microsoft, Meta, Tesla, Joby Aviation, SAP, Royal Caribbean, and More -- Barrons.com

29. jaan 2026, 21:50 UTC

Market Talk

Tulu

Health Care Roundup: Market Talk

29. jaan 2026, 21:50 UTC

Market Talk

Tulu

Auto & Transport Roundup: Market Talk

29. jaan 2026, 21:49 UTC

Tulu

Honeywell Delivers Solid Earnings Ahead of Its Corporate Breakup -- Barrons.com

29. jaan 2026, 21:46 UTC

Tulu

Apple Posts Blowout iPhone Sales on Surging China Demand -- Update

29. jaan 2026, 21:36 UTC

Tulu

Lockheed Martin Stock Jumps on Guidance and Government Missile Deal -- Barrons.com

29. jaan 2026, 21:32 UTC

Tulu

Visa Beats Expectations on Stronger Spending. The Stock Is Falling. -- Barrons.com

29. jaan 2026, 21:32 UTC

Tulu

Sandisk Beats Earnings. The Stock Is Soaring. -- Barrons.com

29. jaan 2026, 21:30 UTC

Tulu

Apple Posts Blowout IPhone Sales on Surging China Demand -- WSJ

29. jaan 2026, 21:30 UTC

Tulu

Apple 1Q Mac Rev $8.39B >AAPL

Võrdlus sarnastega

Hinnamuutus

Lexicon Pharmaceuticals Inc Prognoos

Hinnasiht

By TipRanks

135.67% tõus

12 kuu keskmine prognoos

Keskmine 4.03 USD 135.67%

Kõrge 6 USD

Madal 2.1 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Lexicon Pharmaceuticals Inc 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Lexicon Pharmaceuticals Inc aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

0.6863 / 0.72Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bullish.

There is one bearish event.

Sentiment

By Acuity

302 / 352 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Lexicon Pharmaceuticals Inc

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; and LX9211, which is in Phase II clinical development for the treatment of neuropathic pain and LX2761, which is in Phase I clinical development for gastrointestinal tract. Lexicon Pharmaceuticals, Inc. has strategic collaboration and license agreements with Bristol-Myers Squibb Company and Genentech, Inc. The company was incorporated in 1995 and is headquartered in The Woodlands, Texas.